Anti-rejection drug may eliminate skin cancer

03/31/2005 | NYTimes.com

The immunosuppressive drug sirolimus also reversed a skin cancer, Kaposi's sarcoma, which afflicts kidney transplant patients, according to a study in the New England Journal of Medicine. Fifteen patients who developed cancerous skin lesions while taking other anti-rejection drugs saw the lesions disappear with three months of switching to sirolimus.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD